World’s First Active Bone Conduction Implant
BONEBRIDGE, the world's first active bone conduction implant system, is an effective solution for individuals 12 years and above with lasting hearing loss following a middle ear operation, malformations, or generally for conductive hearing loss and mixed hearing loss. It is also an option for individuals with single-sided deafness.
With conductive or mixed hearing loss, sound cannot take the natural path through the outer and middle ear to the inner ear. With BONEBRIDGE, the sound waves are transmitted via bone conduction directly to the inner ear, where they are processed as natural sound. BONEBRIDGE ensures optimal daily hearing performance while remaining discreet and unobtrusive.
Advantages of the BONEBRIDGE
The direct-drive technology of the implant, along with its advanced signal processing, produces outstanding audiological results. The ear remains unobstructed. This makes BONEBRIDGE a solution for people with pathologies of the ear canal.
Like MED-EL’s cochlear implants and the SOUNDBRIDGE middle ear implant, BONEBRIDGE’s external audio processor can be easily upgraded to a newer generation of device, even years after the original implantation.
BONEBRIDGE is the first active bone conduction implant system that leaves the skin intact, as the implant is placed completely underneath the skin. This ensures an extremely low risk of skin complications, such as infection. The well proven intact-skin technology already established in MED-EL’s cochlear and middle ear implants is now being employed successfully in bone conduction stimulation.